Leaderboards/Salivary Gland Tumors Diagnosis and Treatment

Salivary Gland Tumors Diagnosis and Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Ibrahim Alsanie
King Saud Medical City
2
Camila Paz Muñoz-Grez
University of Concepción
3
Yunlin Zheng
Key Laboratory of Guangdong Province
4
Marie Bannier-Hélaouët
Royal Netherlands Academy of Arts and Sciences
5
Ghazaleh Pourali
Mashhad University of Medical Sciences
6
Yeo‐Jun Yoon
Yonsei University
7
Kubilay Muhammed Sünnetci
Osmaniye Korkut Ata University
8
Loukas Chatzis
Academy of Athens
9
Joris L. Vos
Memorial Sloan Kettering Cancer Center
10
Gerben Lassche
Radboud University Nijmegen

Papers

1
Publication in BMC Microbiology (2024) [50 citations, W4390608760]
BMC Microbiology|2024
50 cit.
2
Human conjunctiva organoids to study ocular surface homeostasis and disease
Cell stem cell|2024
41 cit.
3
A transformer-based deep learning model for early prediction of lymph node metastasis in locally advanced gastric cancer after neoadjuvant chemotherapy using pretreatment CT images
EClinicalMedicine|2024
32 cit.
4
Publication in International Journal of Oral Science (2025) [27 citations, W4405973817]
International Journal of Oral Science|2025
27 cit.
5
Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma
JCI Insight|2024
16 cit.
6
Exploring the feasibility of AI-based analysis of histopathological variability in salivary gland tumours
Scientific Reports|2025
6 cit.
7
Publication in Journal of Imaging Informatics in Medicine (2024) [5 citations, W4403761433]
Journal of Imaging Informatics in Medicine|2024
5 cit.
8
Publication in Journal of Imaging Informatics in Medicine (2024) [4 citations, W4402884576]
Journal of Imaging Informatics in Medicine|2024
4 cit.
9
Publication in Displays (2025) [3 citations, W4409885654]
Displays|2025
3 cit.
10
Mapping the B-cell axis in Sjögren’s disease: repertoire, microenvironment, and potential routes to precision treatment
Current Opinion in Immunology|2025
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Denise Frosina
Memorial Sloan Kettering Cancer Center
2
Ryma Benayed
Memorial Sloan Kettering Cancer Center
3
T. Saotome
Matsudo City Hospital
4
Steven M. Sperry
Vanderbilt University Medical Center
5
Angela M Riegel
United States Air Force
6
Syed Ali Khurram
University of Sheffield
7
Markéta Miesbauerová
Charles University
8
Rema Rao
Cleveland Clinic
9
A. Elattar
University of Pittsburgh
10
Kristine Bjørndal
Odense University Hospital

Papers

1
Distribution and Frequency of Salivary Gland Tumours: An International Multicenter Study
Head and Neck Pathology|2022
139 cit.
2
Prediction of malignant transformation and recurrence of oral epithelial dysplasia using architectural and cytological feature specific prognostic models
Modern Pathology|2022
49 cit.
3
Development and validation of a multivariable model for prediction of malignant transformation and recurrence of oral epithelial dysplasia
British Journal of Cancer|2023
18 cit.
4
Epidemiology, outcomes, and prognostic factors in submandibular gland carcinomas: a national DAHANCA study
European Archives of Oto-Rhino-Laryngology|2023
8 cit.
5
Ameloblastoma with adenoid features: Case report with cyto‐histopathologic correlation and molecular findings
Diagnostic Cytopathology|2022
7 cit.
6
The risk of facial nerve palsy after benign parotidectomy. A quality project
Acta Oto-Laryngologica|2024
7 cit.
7
A head‐to‐head comparison of four grading systems for oral epithelial dysplasia
Histopathology|2024
6 cit.
8
Exploring the feasibility of AI-based analysis of histopathological variability in salivary gland tumours
Scientific Reports|2025
6 cit.
9
Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2023
5 cit.
10
Diagnostic and prognostic biomarkers in salivary gland tumours
Diagnostic histopathology|2023
4 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Adel K. El‐Naggar
Barking, Havering And Redbridge University Hospitals NHS Trust
2
Luiz Paulo Kowalski
Translational Research in Oncology
3
Göran Stenman
University of Gothenburg
4
Heinrich Iro
Friedrich-Alexander-Universität Erlangen-Nürnberg
5
Christopher D.�M. Fletcher
Brigham and Women's Hospital
6
Raja R. Seethala
University of Pittsburgh
7
Matthew Meyerson
Broad Institute
8
Haralampos Μ. Moutsopoulos
Academy of Athens
9
Ilmo Leivo
Turku University Hospital
10
Benjamin Castleman
Harvard University

Papers

1
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Science|2004
9.4k cit.
2
The landscape of somatic copy-number alteration across human cancers
Nature|2010
4.1k cit.
3
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
Lund University Publications (Lund University)|2002
2.8k cit.
4
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
Proceedings of the National Academy of Sciences|2001
2.6k cit.
5
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
Genome Research|2011
2k cit.
6
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Cell|2012
1.8k cit.
7
hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization
Cell|1997
1.8k cit.
8
Localized mediastinal lymph-node hyperplasia resembling thymoma
Cancer|1956
1.6k cit.
9
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
Science|2017
1.5k cit.
10
Hyaline‐vascular and plasma‐cell types of giant lymph node hyperplasia of the mediastinum and other locations
Cancer|1972
1.4k cit.

Reagents for Salivary Gland Tumors Diagnosis and Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Agilent/Dako

Cytokeratin 19

#M0888
View Evidence →
Agilent/Dako

CD 117 (c-Kit, SCF-Receptor)

#A4502
View Evidence →
Agilent/Dako

Amplified in squamous cell carcinoma p63

#M7247
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

CDX2 (D11D10) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 6 papers
#18744$465
View Evidence →
Agilent/DakoEvidence 65

IgG

Cited in 5 papers
#A0423
View Evidence →
Agilent/Dako

p53 Tumor Suppressor Protein

Cited in 5 papers
#M7001
View Evidence →